Archimica Cooperatief U.A.

During the period of TowerBrook Fund II’s investment, Archimica was a manufacturer of Active Pharmaceutical Ingredients (APIs) and late stage intermediates for the pharmaceutical industry. An API is the active molecule in a drug and is the component of the final pharmaceutical product that gives it its remedial properties. TowerBrook exited its investment in 2011 via the sale of Archimica to Italian pharmaceutical chemicals company Euticals (Prime European Therapeutical SpA).